- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 36 x SO4: SULFATE ION(Non-functional Binders)
- 4 x 04A: N,N'-[sulfanediylbis(ethane-2,1-diyl-1,3,4-thiadiazole-5,2-diyl)]bis(2-phenylacetamide)(Non-covalent)
04A.10: 15 residues within 4Å:- Chain A: K.102, L.103, F.104, L.105, N.106, E.107, Y.176
- Chain B: K.102, L.103, F.104, L.105, N.106, E.107, Y.176
- Ligands: 04A.20
13 PLIP interactions:5 interactions with chain A, 8 interactions with chain B- Hydrophobic interactions: A:F.104, A:E.107, A:Y.176, B:L.103, B:F.104, B:E.107, B:Y.176
- Hydrogen bonds: A:F.104, A:L.105, B:F.104, B:L.105
- Water bridges: B:Y.176, B:Y.176
04A.20: 15 residues within 4Å:- Chain A: K.102, L.103, F.104, L.105, N.106, E.107, Y.176
- Chain B: K.102, L.103, F.104, L.105, N.106, E.107, Y.176
- Ligands: 04A.10
13 PLIP interactions:6 interactions with chain A, 7 interactions with chain B- Hydrophobic interactions: A:L.103, A:F.104, A:E.107, A:Y.176, B:F.104, B:E.107, B:Y.176
- Hydrogen bonds: A:F.104, A:L.105, B:F.104, B:L.105
- Water bridges: B:Y.176, B:Y.176
04A.30: 15 residues within 4Å:- Chain C: K.102, L.103, F.104, L.105, N.106, E.107, Y.176
- Chain D: K.102, L.103, F.104, L.105, N.106, E.107, Y.176
- Ligands: 04A.40
13 PLIP interactions:8 interactions with chain D, 5 interactions with chain C- Hydrophobic interactions: D:L.103, D:F.104, D:E.107, D:Y.176, C:F.104, C:E.107, C:Y.176
- Hydrogen bonds: D:F.104, D:L.105, C:F.104, C:L.105
- Water bridges: D:Y.176, D:Y.176
04A.40: 15 residues within 4Å:- Chain C: K.102, L.103, F.104, L.105, N.106, E.107, Y.176
- Chain D: K.102, L.103, F.104, L.105, N.106, E.107, Y.176
- Ligands: 04A.30
13 PLIP interactions:7 interactions with chain D, 6 interactions with chain C- Hydrophobic interactions: D:F.104, D:E.107, D:Y.176, C:L.103, C:F.104, C:E.107, C:Y.176
- Hydrogen bonds: D:F.104, D:L.105, C:F.104, C:L.105
- Water bridges: D:Y.176, D:Y.176
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Finlay, M.R.V. et al., Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models. J Med Chem (2019)
- Release Date
- 2023-01-18
- Peptides
- Glutaminase kidney isoform, mitochondrial 65 kDa chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 36 x SO4: SULFATE ION(Non-functional Binders)
- 4 x 04A: N,N'-[sulfanediylbis(ethane-2,1-diyl-1,3,4-thiadiazole-5,2-diyl)]bis(2-phenylacetamide)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Finlay, M.R.V. et al., Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models. J Med Chem (2019)
- Release Date
- 2023-01-18
- Peptides
- Glutaminase kidney isoform, mitochondrial 65 kDa chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A